Correction

Following the publication of our article [1] we noticed an error in the Methods section. In the sub-section 'Describing baseline prevalence of medication-related problems' the denominator for the following secondary outcome measures is incorrectly stated:

Patients prescribed amiodarone for ≥ six months without a thyroid function test in the last six months (numerator)/

Patients prescribed amiodarone for ≥ three months (denominator)

This should read:

Patients prescribed amiodarone for ≥ six months without a thyroid function test in the last six months (numerator)/

Patients prescribed amiodarone for ≥ six months (denominator)